Sandoz gets OK for generic Yaz
PRINCETON, N.J. — The Food and Drug Administration has approved a generic oral contraceptive made by Sandoz, the generics arm of Swiss drug maker Novartis said Wednesday.
Sandoz announced the approval of Loryna (drospirenone 3 mg and ethinyl estradiol 0.02 mg) tablets, a generic version of Bayer HealthCare Pharmaceuticals’ Yaz.
Sandoz is the second company to launch a generic version of Yaz. The company’s portfolio of generic oral contraceptives also includes Altavera (levonorgestrel and ethinyl estradiol) tablets, a generic version of Duramed’s Nordette; and Introvale (levonorgestrel and ethinyl estradiol) tablets, a generic version of Duramed’s Seasonale.
Branded and generic versions of Yaz had about $578 million in sales during the 12 months ended in February, according to IMS Health.
NACDS Foundation appoints new board member
SCOTTSDALE, Ariz. — The National Association of Chain Drug Stores Foundation has elected a Coca-Cola executive to its board of directors.
Diane Wallace will join the NACDS Foundation’s board for a one-year term. Additionally, NACDS president and CEO Steve Anderson was elected to serve as chairman of the NACDS Foundation board of directors; Edith Rosato will serve as president; R. James Huber, NACDS EVP and CFO, will serve as treasurer; and Nicki Robins, NACDS assistant general counsel, will serve as secretary. All officers will serve a one-year term.
Including Wallace, the NACDS Foundation board of directors will have 22 members.
“We welcome Diane Wallace to the NACDS Foundation board, and look forward to working with her in her new capacity,” said NACDS Foundation president Edith Rosato. “The NACDS Foundation board members represent all facets of the pharmacy community — retailers, pharmaceutical companies and consumer product businesses — and together as a cohesive unit, we strive to implement the foundation’s vision and mission to improve and advance public health and wellness.”
FDA warns consumers over fake products that claim to treat STDs
SILVER SPRING, Md. — The Food and Drug Administration is cracking down on companies that it accuses of selling fake products for sexually transmitted diseases, the agency said.
The FDA said at least 15 products — some sold as dietary supplements — that claim to treat, prevent or cure such STDs as herpes, Chlamydia, genital warts and HIV/AIDS, were being sold online and at some retail stores. Brands include MedaVir, which claims to treat herpes; Gene-Eden, which claims to treat a range of STDs, as well as flu and mononucleosis; and several others.
“If you aren’t treating your STD with an FDA-approved medication, you’re not just putting your own health at risk — you could be endangering your partner,” FDA expert Debbie Birnkrant said.
The agency sent warning letters to 12 companies making the products, ordering them to stop or face regulatory action.